- Home
- ALAR vs NVNO Comparison
ALAR vs NVNO Comparison
Compare ALAR & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- NVNO
- Stock Information
- Founded
- ALAR 2013
- NVNO 1987
- Country
- ALAR Israel
- NVNO United States
- Employees
- ALAR N/A
- NVNO N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- NVNO Medical/Dental Instruments
- Sector
- ALAR Technology
- NVNO Health Care
- Exchange
- ALAR Nasdaq
- NVNO Nasdaq
- Market Cap
- ALAR 94.0M
- NVNO 51.7M
- IPO Year
- ALAR 2018
- NVNO N/A
- Fundamental
- Price
- ALAR $11.24
- NVNO $2.49
- Analyst Decision
- ALAR Strong Buy
- NVNO
- Analyst Count
- ALAR 2
- NVNO 0
- Target Price
- ALAR $24.00
- NVNO N/A
- AVG Volume (30 Days)
- ALAR 233.2K
- NVNO 156.1K
- Earning Date
- ALAR 11-25-2024
- NVNO 10-31-2024
- Dividend Yield
- ALAR N/A
- NVNO N/A
- EPS Growth
- ALAR N/A
- NVNO N/A
- EPS
- ALAR 0.10
- NVNO N/A
- Revenue
- ALAR $31,561,000.00
- NVNO N/A
- Revenue This Year
- ALAR $22.15
- NVNO N/A
- Revenue Next Year
- ALAR $11.59
- NVNO N/A
- P/E Ratio
- ALAR $10.77
- NVNO N/A
- Revenue Growth
- ALAR 40.80
- NVNO N/A
- 52 Week Low
- ALAR $4.92
- NVNO $2.45
- 52 Week High
- ALAR $46.69
- NVNO $6.97
- Technical
- Relative Strength Index (RSI)
- ALAR 40.46
- NVNO 23.71
- Support Level
- ALAR $10.41
- NVNO $2.90
- Resistance Level
- ALAR $12.34
- NVNO $2.93
- Average True Range (ATR)
- ALAR 0.76
- NVNO 0.18
- MACD
- ALAR -0.11
- NVNO -0.04
- Stochastic Oscillator
- ALAR 23.75
- NVNO 4.76
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a company engaged in the information security business. The company has two Internet access segments which include Enterprise Internet Access and Consumer Internet Access. Its Enterprise Internet Access offers web data collection and a private Internet browsing platform and Consumer Internet Access provides solutions for secure and private Internet browsing. Geographically, the company has a presence in the UK Virgin Islands, Israel, Europe, APAC, MEA, Hong Kong, the USA, and others, and generates a majority of its revenue from the APAC followed by the United States.
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).